Abstract 36 Table 1
Agree to trial?
Yes (n=30)No (n=16)P-value
Gender, N (% Female)22 (73%)13 (81%)0.72
Age, mean (SD)52 (15)58 (17)0.78
First Degree Relatives with RA, N (% Yes)17 (57%)2 (13%)<0.01*
Education, N (% Some College or Greater)27 (90%)15 (94%)1.00
Benefit to Me, median (range)4 (2,4)1.5 (0,4)<0.01*
Benefit to my Family4 (0,4)1 (0,4)0.01*
Benefit to Others4 (2,4)1 (0,4)<0.01*
Risk of developing RA4 (0,4)2.5 (0,4)0.03*
Potential Positive Side Effects3 (1,4)1 (0,4)0.02*
Potential Negative Side Effects2 (0,4)4 (0,4)<0.01*
  • 0=no opinion; 1=not at all; 2=a little; 3=somewhat; 4=very much;Time, Compensation, Moral Obligation, to Learn About RA and the Potential for Receiving a Placebo were not statistically different between groups.